Ticker brief

CDNA

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
8
authors 14d
8
crowd 14d
+0.7σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-08-23 → 2026-08-27 · now +0.20 (−1 bearish … +1 bullish)
Who spoke8
authorgradetrader scoresignalsmean sent
@TedHZhangB+0.571+0.45
@MichaelWigginsOB-1.691+0.85
@GnT_TradesC+1.701+0.45
@DrStoxxC-1.581+0.35
@LeifSoreideC+0.011+0.75
@MinervaCapC-0.391+0.15
@PatrickWalker56C-0.041+0.65
@MartyCharginC-0.271+0.20
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-27@MartyChargin+0.20Vocal reaction appears approving but depends on the unseen chart.·
2026-08-26@PatrickWalker56+0.65Views CareDx closing at the day's high as a sign of strength.·
2026-08-25@MinervaCap+0.15Daily watchlist names top trades for tomorrow without explicit entry intent.·
2026-08-25@LeifSoreide+0.75Long CDNA on a textbook high-tight-flag setup despite its speculative risk. — Explicitly discloses a new bullish CDNA trade based on a high-tight-flag chart pattern.·
2026-08-25@DrStoxx+0.35Discloses room and portfolio holdings, including calls and leveraged ETFs.·
2026-08-24@GnT_Trades+0.45Describes CDNA's biotech-relative chart as attractive, with detail in media.·
2026-08-24@MichaelWigginsO+0.85Buy CDNA's inflection and hold patiently for a $75 target by the end of 2027. — Presents a forward buy thesis and explicit $75 end-2027 target based on revenue, FCF and valuation assumptions.·
2026-08-23@TedHZhang+0.45Genomics and healthcare are identified as primary investment themes alongside crypto.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.